APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ertapenem Sodium for Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ertapenem Sodium for Injection Market Outlook and Growth Opportunities 2026

26 December 2025197 pages

Choose your research edition.

Industry ResearchErtapenem Sodium for Injection Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Ertapenem Sodium for Injection Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Ertapenem Sodium for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ertapenem Sodium for Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Ertapenem Sodium for Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Ertapenem Sodium for Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ertapenem Sodium for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ertapenem Sodium for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ertapenem Sodium for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ertapenem Sodium for Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ertapenem Sodium for Injection market include Chongqing Shenghuaxi Pharmaceutical Co., Ltd., Sichuan Pharmaceutical Preparation Co., Ltd., Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd., Qilu Anti Pharmaceutical Co., Ltd., Hainan Herui Pharmaceutical Co., Ltd., Unitech Biotech, Par Pharmaceutical, NorthStar Rx and Intelicure Lifesciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ertapenem Sodium for Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ertapenem Sodium for Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ertapenem Sodium for Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ertapenem Sodium for Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Ertapenem Sodium for Injection Segment by Company

Chongqing Shenghuaxi Pharmaceutical Co., Ltd.

Sichuan Pharmaceutical Preparation Co., Ltd.

Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.

Qilu Anti Pharmaceutical Co., Ltd.

Hainan Herui Pharmaceutical Co., Ltd.

Unitech Biotech

Par Pharmaceutical

NorthStar Rx

Intelicure Lifesciences

EUGIA PHARMA INC

ACS DOBFAR SPA

Ertapenem Sodium for Injection Segment by Type

0.5g

1g

Ertapenem Sodium for Injection Segment by Application

Hospital

Clinic

Other

Ertapenem Sodium for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ertapenem Sodium for Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ertapenem Sodium for Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ertapenem Sodium for Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Ertapenem Sodium for Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ertapenem Sodium for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ertapenem Sodium for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ertapenem Sodium for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ertapenem Sodium for Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ertapenem Sodium for Injection industry.

Chapter 3: Detailed analysis of Ertapenem Sodium for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ertapenem Sodium for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ertapenem Sodium for Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ertapenem Sodium for Injection Industry Trends Table 2. Ertapenem Sodium for Injection Industry Drivers Table 3. Ertapenem Sodium for Injection Industry Opportunities and Challenges Table 4. Ertapenem Sodium for Injection Industry Restraints Table 5. Global Ertapenem Sodium for Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ertapenem Sodium for Injection Revenue Share by Company (2021-2026) Table 7. Global Ertapenem Sodium for Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Ertapenem Sodium for Injection Sales Volume Share by Company (2021-2026) Table 9. Global Ertapenem Sodium for Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Ertapenem Sodium for Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ertapenem Sodium for Injection Key Company Manufacturing Base & Headquarters Table 12. Global Ertapenem Sodium for Injection Company, Product Type & Application Table 13. Global Ertapenem Sodium for Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ertapenem Sodium for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 0.5g Table 18. Significant Companies of 1g Table 19. Global Ertapenem Sodium for Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Ertapenem Sodium for Injection Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Ertapenem Sodium for Injection Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Ertapenem Sodium for Injection Sales Volume Share by Type (2021-2026) Table 23. Global Ertapenem Sodium for Injection Sales Volume Share by Type (2027-2032) Table 24. Global Ertapenem Sodium for Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Ertapenem Sodium for Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Ertapenem Sodium for Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Ertapenem Sodium for Injection Sales Value Share by Type (2021-2026) Table 28. Global Ertapenem Sodium for Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Ertapenem Sodium for Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Ertapenem Sodium for Injection Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Ertapenem Sodium for Injection Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Ertapenem Sodium for Injection Sales Volume Share by Application (2021-2026) Table 36. Global Ertapenem Sodium for Injection Sales Volume Share by Application (2027-2032) Table 37. Global Ertapenem Sodium for Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Ertapenem Sodium for Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Ertapenem Sodium for Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Ertapenem Sodium for Injection Sales Value Share by Application (2021-2026) Table 41. Global Ertapenem Sodium for Injection Sales Value Share by Application (2027-2032) Table 42. Global Ertapenem Sodium for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Ertapenem Sodium for Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Ertapenem Sodium for Injection Sales Market Share by Region (2021-2026) Table 45. Global Ertapenem Sodium for Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Ertapenem Sodium for Injection Sales Market Share by Region (2027-2032) Table 47. Global Ertapenem Sodium for Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Ertapenem Sodium for Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Ertapenem Sodium for Injection Sales Value Share by Region (2021-2026) Table 50. Global Ertapenem Sodium for Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Ertapenem Sodium for Injection Sales Value Share by Region (2027-2032) Table 52. Global Ertapenem Sodium for Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Ertapenem Sodium for Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Ertapenem Sodium for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Ertapenem Sodium for Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Ertapenem Sodium for Injection Sales by Country (2021-2026) & (K Units) Table 57. Global Ertapenem Sodium for Injection Sales Market Share by Country (2021-2026) Table 58. Global Ertapenem Sodium for Injection Sales by Country (2027-2032) & (K Units) Table 59. Global Ertapenem Sodium for Injection Sales Market Share by Country (2027-2032) Table 60. Global Ertapenem Sodium for Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Ertapenem Sodium for Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Ertapenem Sodium for Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Ertapenem Sodium for Injection Sales Value Market Share by Country (2027-2032) Table 64. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Company Information Table 65. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Business Overview Table 66. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 68. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Recent Development Table 69. Sichuan Pharmaceutical Preparation Co., Ltd. Company Information Table 70. Sichuan Pharmaceutical Preparation Co., Ltd. Business Overview Table 71. Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 73. Sichuan Pharmaceutical Preparation Co., Ltd. Recent Development Table 74. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information Table 75. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview Table 76. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 78. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Development Table 79. Qilu Anti Pharmaceutical Co., Ltd. Company Information Table 80. Qilu Anti Pharmaceutical Co., Ltd. Business Overview Table 81. Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 83. Qilu Anti Pharmaceutical Co., Ltd. Recent Development Table 84. Hainan Herui Pharmaceutical Co., Ltd. Company Information Table 85. Hainan Herui Pharmaceutical Co., Ltd. Business Overview Table 86. Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 88. Hainan Herui Pharmaceutical Co., Ltd. Recent Development Table 89. Unitech Biotech Company Information Table 90. Unitech Biotech Business Overview Table 91. Unitech Biotech Ertapenem Sodium for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Unitech Biotech Ertapenem Sodium for Injection Product Portfolio Table 93. Unitech Biotech Recent Development Table 94. Par Pharmaceutical Company Information Table 95. Par Pharmaceutical Business Overview Table 96. Par Pharmaceutical Ertapenem Sodium for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Par Pharmaceutical Ertapenem Sodium for Injection Product Portfolio Table 98. Par Pharmaceutical Recent Development Table 99. NorthStar Rx Company Information Table 100. NorthStar Rx Business Overview Table 101. NorthStar Rx Ertapenem Sodium for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. NorthStar Rx Ertapenem Sodium for Injection Product Portfolio Table 103. NorthStar Rx Recent Development Table 104. Intelicure Lifesciences Company Information Table 105. Intelicure Lifesciences Business Overview Table 106. Intelicure Lifesciences Ertapenem Sodium for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Intelicure Lifesciences Ertapenem Sodium for Injection Product Portfolio Table 108. Intelicure Lifesciences Recent Development Table 109. EUGIA PHARMA INC Company Information Table 110. EUGIA PHARMA INC Business Overview Table 111. EUGIA PHARMA INC Ertapenem Sodium for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. EUGIA PHARMA INC Ertapenem Sodium for Injection Product Portfolio Table 113. EUGIA PHARMA INC Recent Development Table 114. ACS DOBFAR SPA Company Information Table 115. ACS DOBFAR SPA Business Overview Table 116. ACS DOBFAR SPA Ertapenem Sodium for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. ACS DOBFAR SPA Ertapenem Sodium for Injection Product Portfolio Table 118. ACS DOBFAR SPA Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Ertapenem Sodium for Injection Distributors List Table 122. Ertapenem Sodium for Injection Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Ertapenem Sodium for Injection Product Image Figure 2. Global Ertapenem Sodium for Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ertapenem Sodium for Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ertapenem Sodium for Injection Sales (2021-2032) & (K Units) Figure 5. Global Ertapenem Sodium for Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Ertapenem Sodium for Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 0.5g Image Figure 10. 1g Image Figure 11. Global Ertapenem Sodium for Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Ertapenem Sodium for Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Ertapenem Sodium for Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Ertapenem Sodium for Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Ertapenem Sodium for Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Ertapenem Sodium for Injection Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Ertapenem Sodium for Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Ertapenem Sodium for Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Ertapenem Sodium for Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Ertapenem Sodium for Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Ertapenem Sodium for Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Ertapenem Sodium for Injection Sales Value Share by Application (2021-2032) Figure 26. Global Ertapenem Sodium for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Ertapenem Sodium for Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Ertapenem Sodium for Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Ertapenem Sodium for Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Ertapenem Sodium for Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Ertapenem Sodium for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Ertapenem Sodium for Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Ertapenem Sodium for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Ertapenem Sodium for Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Ertapenem Sodium for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Ertapenem Sodium for Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Ertapenem Sodium for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Ertapenem Sodium for Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Ertapenem Sodium for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Ertapenem Sodium for Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Ertapenem Sodium for Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5g
  • 1g
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Chongqing Shenghuaxi Pharmaceutical Co., Ltd.
  • Sichuan Pharmaceutical Preparation Co., Ltd.
  • Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
  • Qilu Anti Pharmaceutical Co., Ltd.
  • Hainan Herui Pharmaceutical Co., Ltd.
  • Unitech Biotech
  • Par Pharmaceutical
  • NorthStar Rx
  • Intelicure Lifesciences
  • EUGIA PHARMA INC
  • ACS DOBFAR SPA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ertapenem Sodium for Injection Sales Value (2021-2032)
  4. 1.2.2 Global Ertapenem Sodium for Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Ertapenem Sodium for Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ertapenem Sodium for Injection Market Dynamics
  1. 2.1 Ertapenem Sodium for Injection Industry Trends
  2. 2.2 Ertapenem Sodium for Injection Industry Drivers
  3. 2.3 Ertapenem Sodium for Injection Industry Opportunities and Challenges
  4. 2.4 Ertapenem Sodium for Injection Industry Restraints
3 Ertapenem Sodium for Injection Market by Company
  1. 3.1 Global Ertapenem Sodium for Injection Company Revenue Ranking in 2025
  2. 3.2 Global Ertapenem Sodium for Injection Revenue by Company (2021-2026)
  3. 3.3 Global Ertapenem Sodium for Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Ertapenem Sodium for Injection Average Price by Company (2021-2026)
  5. 3.5 Global Ertapenem Sodium for Injection Company Ranking (2024-2026)
  6. 3.6 Global Ertapenem Sodium for Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Ertapenem Sodium for Injection Company Product Type and Application
  8. 3.8 Global Ertapenem Sodium for Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ertapenem Sodium for Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ertapenem Sodium for Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ertapenem Sodium for Injection Market by Type
  1. 4.1 Ertapenem Sodium for Injection Type Introduction
  2. 4.1.1 0.5g
  3. 4.1.2 1g
  4. 4.2 Global Ertapenem Sodium for Injection Sales Volume by Type
  5. 4.2.1 Global Ertapenem Sodium for Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ertapenem Sodium for Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Ertapenem Sodium for Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Ertapenem Sodium for Injection Sales Value by Type
  9. 4.3.1 Global Ertapenem Sodium for Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Ertapenem Sodium for Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Ertapenem Sodium for Injection Sales Value Share by Type (2021-2032)
5 Ertapenem Sodium for Injection Market by Application
  1. 5.1 Ertapenem Sodium for Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Ertapenem Sodium for Injection Sales Volume by Application
  6. 5.2.1 Global Ertapenem Sodium for Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ertapenem Sodium for Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Ertapenem Sodium for Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Ertapenem Sodium for Injection Sales Value by Application
  10. 5.3.1 Global Ertapenem Sodium for Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ertapenem Sodium for Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Ertapenem Sodium for Injection Sales Value Share by Application (2021-2032)
6 Ertapenem Sodium for Injection Regional Sales and Value Analysis
  1. 6.1 Global Ertapenem Sodium for Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ertapenem Sodium for Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Ertapenem Sodium for Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Ertapenem Sodium for Injection Sales by Region (2027-2032)
  5. 6.3 Global Ertapenem Sodium for Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ertapenem Sodium for Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ertapenem Sodium for Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ertapenem Sodium for Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Ertapenem Sodium for Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ertapenem Sodium for Injection Sales Value (2021-2032)
  12. 6.6.2 North America Ertapenem Sodium for Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ertapenem Sodium for Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Ertapenem Sodium for Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ertapenem Sodium for Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ertapenem Sodium for Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ertapenem Sodium for Injection Sales Value (2021-2032)
  21. 6.9.2 South America Ertapenem Sodium for Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ertapenem Sodium for Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ertapenem Sodium for Injection Sales Value Share by Country, 2025 VS 2032
7 Ertapenem Sodium for Injection Country-level Sales and Value Analysis
  1. 7.1 Global Ertapenem Sodium for Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ertapenem Sodium for Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ertapenem Sodium for Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Ertapenem Sodium for Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Ertapenem Sodium for Injection Sales by Country (2027-2032)
  6. 7.4 Global Ertapenem Sodium for Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ertapenem Sodium for Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ertapenem Sodium for Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ertapenem Sodium for Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ertapenem Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ertapenem Sodium for Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Shenghuaxi Pharmaceutical Co., Ltd.
  2. 8.1.1 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  6. 8.1.5 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Sichuan Pharmaceutical Preparation Co., Ltd.
  8. 8.2.1 Sichuan Pharmaceutical Preparation Co., Ltd. Company Information
  9. 8.2.2 Sichuan Pharmaceutical Preparation Co., Ltd. Business Overview
  10. 8.2.3 Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  12. 8.2.5 Sichuan Pharmaceutical Preparation Co., Ltd. Recent Developments
  13. 8.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
  14. 8.3.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  18. 8.3.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Qilu Anti Pharmaceutical Co., Ltd.
  20. 8.4.1 Qilu Anti Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Qilu Anti Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  24. 8.4.5 Qilu Anti Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Hainan Herui Pharmaceutical Co., Ltd.
  26. 8.5.1 Hainan Herui Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Hainan Herui Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  30. 8.5.5 Hainan Herui Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Unitech Biotech
  32. 8.6.1 Unitech Biotech Company Information
  33. 8.6.2 Unitech Biotech Business Overview
  34. 8.6.3 Unitech Biotech Ertapenem Sodium for Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Unitech Biotech Ertapenem Sodium for Injection Product Portfolio
  36. 8.6.5 Unitech Biotech Recent Developments
  37. 8.7 Par Pharmaceutical
  38. 8.7.1 Par Pharmaceutical Company Information
  39. 8.7.2 Par Pharmaceutical Business Overview
  40. 8.7.3 Par Pharmaceutical Ertapenem Sodium for Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Par Pharmaceutical Ertapenem Sodium for Injection Product Portfolio
  42. 8.7.5 Par Pharmaceutical Recent Developments
  43. 8.8 NorthStar Rx
  44. 8.8.1 NorthStar Rx Company Information
  45. 8.8.2 NorthStar Rx Business Overview
  46. 8.8.3 NorthStar Rx Ertapenem Sodium for Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 NorthStar Rx Ertapenem Sodium for Injection Product Portfolio
  48. 8.8.5 NorthStar Rx Recent Developments
  49. 8.9 Intelicure Lifesciences
  50. 8.9.1 Intelicure Lifesciences Company Information
  51. 8.9.2 Intelicure Lifesciences Business Overview
  52. 8.9.3 Intelicure Lifesciences Ertapenem Sodium for Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Intelicure Lifesciences Ertapenem Sodium for Injection Product Portfolio
  54. 8.9.5 Intelicure Lifesciences Recent Developments
  55. 8.10 EUGIA PHARMA INC
  56. 8.10.1 EUGIA PHARMA INC Company Information
  57. 8.10.2 EUGIA PHARMA INC Business Overview
  58. 8.10.3 EUGIA PHARMA INC Ertapenem Sodium for Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 EUGIA PHARMA INC Ertapenem Sodium for Injection Product Portfolio
  60. 8.10.5 EUGIA PHARMA INC Recent Developments
  61. 8.11 ACS DOBFAR SPA
  62. 8.11.1 ACS DOBFAR SPA Company Information
  63. 8.11.2 ACS DOBFAR SPA Business Overview
  64. 8.11.3 ACS DOBFAR SPA Ertapenem Sodium for Injection Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 ACS DOBFAR SPA Ertapenem Sodium for Injection Product Portfolio
  66. 8.11.5 ACS DOBFAR SPA Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ertapenem Sodium for Injection Value Chain Analysis
  2. 9.1.1 Ertapenem Sodium for Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ertapenem Sodium for Injection Sales Mode & Process
  6. 9.2 Ertapenem Sodium for Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ertapenem Sodium for Injection Distributors
  9. 9.2.3 Ertapenem Sodium for Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst